Home > Healthcare > Medical Devices > Therapeutic Devices > peripheral intravenous catheters market
Get a free sample of Peripheral Intravenous Catheters Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Peripheral Intravenous Catheters Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Peripheral Intravenous Catheters Market size was valued at around USD 5.4 billion in 2023 and is expected to grow at a CAGR of 7.7% from 2024 to 2032. Factors such as advancements in catheter technology, prevalence of infectious diseases, increasing awareness level along with favorable government initiatives and healthcare policies are propelling the market growth.
The growing trend of home healthcare and outpatient services has led to an increased use of peripheral IV catheters outside traditional hospital settings. Patients receiving long-term treatments or palliative care at home may require peripheral IV access. For instance, as per the data reported by CareCentrix, Inc., around 95% of the payors said that treating a patient at home is cost-effective in long-term term as compared to facility treatment.
Additionally, more than 48% of all the payors have made available the at-home health care options to consumers wherever possible, and another 36% are in the process of making it possible for their consumers. Further, increasing prevalence of various disorders such as urinary, cardiovascular, etc. are expected to fuel the market development.
Peripheral intravenous catheters (PIVC) are medical devices that are used to provide temporary access to the bloodstream for the intravenous administration of fluids, medications, and other therapeutic treatments. These catheters are inserted into peripheral veins, which are veins located in the arms, hands, legs, or feet.
Peripheral intravenous catheters industry reached USD 5.4 billion in 2023 and is set to expand at a 7.7% CAGR from 2024-2032 driven by the advancements in catheter technology, the prevalence of infectious diseases along with favorable government initiatives and healthcare policies.
Short peripheral intravenous catheter (PIVC) market generated more than USD 3.6 billion in revenue in 2023 and is projected to witness high demand through 2032 attributed to the benefits of ease of insertion, simplicity of use, and cost-effectiveness.
North America peripheral intravenous catheters industry was USD 1.8 billion in revenue in 2023 and is poised to record substantial gains by the end of 2032 driven by the presence of a well-established healthcare infrastructure.
Some of the leading peripheral intravenous catheter firms are AngioDynamics, Inc., Becton, Dickinson and Company, Boston Scientific Corporation, ICU Medical, Inc., Lineus Medical, MedSource Labs, Retractable Technologies Inc., Teleflex Incorporated, Terumo Corporation, VOGT Medical, and Vygon.